Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histone H3.3 (family member 3B), encoded by the H3F3B gene, is a highly conserved histone variant involved in the formation of nucleosomes, the fundamental units of chromatin in eukaryotic cells[1][3]. Unlike canonical histone H3 (e.g., H3.1, H3.2), H3.3 is incorporated into chromatin independently of DNA replication and throughout the cell cycle by specialized histone chaperones (notably HIRA and DAXX complexes)[1][4]. H3.3 is found at actively transcribed regions, regulatory elements, and also in certain types of heterochromatin, participating in the dynamic regulation of gene expression, epigenetic memory, DNA repair, and chromosomal stability[1][2][4]. Mutations in H3-3B and its paralog H3F3A are implicated in various cancers (as driver mutations) and some neurodevelopmental syndromes[2][3][4]. No direct drugs target histone H3.3 clinically due to its fundamental role in chromatin integrity and cellular homeostasis.
not applicable (no drugs listed); in cancer, disease often results from gain- or loss-of-function mutations affecting chromatin states rather than direct pharmacological modulation[4]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histone H3.3 (family member 3B) (H3-3B).